At BIOMIMETICS SYMPATHIES, we are advancing various business activities centered on regenerative medicine.
We keep challenging to turn a “refractory disease” into a “curable disease”.
Our company is currently engaged in the research and development of effective treatments for two diseases: “cancerous skin ulcers associated with breast cancer (fungating breast cancer)” and “sepsis.” We would like to introduce our recent progress of new drugs for those two diseases.Learn more
Search for new drugs
At our company, we are also focusing on the discovery of new drug seeds by studying the effects of MSC on diseases. We discuss our goals we would like to achieve through showing some examples of new drug seed against COVID-19.Learn more
Business support for regenerative medicines
We provide a wide range of support for medical institutions and companies based on our extensive experience and expertise in regenerative medicine that we have cultivated ahead in Japan. We provide broad consulting services related to regenerative medicine, including the design of cell culture processing facilities, facility operations, education and training, support for the cosmetics business, and others.Learn more
To meet the needs of pharmaceutical companies and medical institutions in Japan and overseas, we provide licenses for AOF media for Designed MSCs, MSC culture technology, and investigational products. Please also consult us about the transfer of other know-how and patents held by our company.Learn more